作者:Hervé Geneste、Swati Bhowmik、Marcel M. van Gaalen、Wilfried Hornberger、Charles W. Hutchins、Astrid Netz、Thorsten Oost、Liliane Unger
DOI:10.1016/j.bmcl.2018.07.043
日期:2018.10
Herein we report the discovery of a novel oxindole-based series of vasopressin 1b (V1b) receptor antagonists. Introducing a substituted piperazine moiety and optimizing the southern and the northern aromatic rings resulted in potent, selective and brain penetrant V1b receptor antagonists. Compound 9c was found to be efficacious in a rat model of anti-depressant activity (3 mg/kg, ip). Interestingly
在这里,我们报告发现一种新型的基于羟吲哚的系列加压素1b(V1b)受体拮抗剂。引入取代的哌嗪部分并优化南部和北部芳香环可产生有效,选择性和脑渗透性的V1b受体拮抗剂。发现化合物9c在抗抑郁活性的大鼠模型(3mg / kg,ip)中有效。有趣的是,尽管微粒体稳定性欠佳,但仍可实现中等的终末半衰期和中等的生物利用度。